Gas-x
NDC Package 0067-0113-36

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Gas-x is a medication used to relieve symptoms of extra gas such as belching, bloating, and feelings of pressure/discomfort in the stomach/gut. Marketed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc, this product is identified by NDC 0067-0113 and is authorized under FDA application part332.

Identification & Billing

NDC Package Code
0067-0113-36
Package Description
2 BLISTER PACK in 1 CARTON / 18 TABLET, CHEWABLE in 1 BLISTER PACK
Product Code
0067-0113
11-Digit Billing Format
00067011336
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
2 EA

Clinical Specifications

Proprietary Name
Gas-x Regular Strength Chewable Cherry
Dosage Form
-
Usage Information
This product is used to relieve symptoms of extra gas such as belching, bloating, and feelings of pressure/discomfort in the stomach/gut. Simethicone helps break up gas bubbles in the gut.

Regulatory & Marketing

Labeler Name
Glaxosmithkline Consumer Healthcare Holdings (us) Llc
FDA Application #
part332
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
01-01-2012
End Marketing Date
07-31-2018
Listing Expiration
07-31-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0067-0113-36 identifies a specific commercial package of 2 blister pack in 1 carton / 18 tablet, chewable in 1 blister pack of Gas-x Regular Strength Chewable Cherry, labeled by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Glaxosmithkline Consumer Healthcare Holdings (us) Llc on January 01, 2012. The current certification is valid through July 31, 2018.

What are the primary indications for this medication?

This product is used to relieve symptoms of extra gas such as belching, bloating, and feelings of pressure/discomfort in the stomach/gut. Simethicone helps break up gas bubbles in the gut.

How is this Glaxosmithkline Consumer Healthcare Holdings (us) Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00067011336. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0067-0113-36
11-Digit CMS (5-4-2)
00067-0113-36

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.